Réaction #306964

ord-677fe82040674e12b4013cc18fab207c

Équation de réaction

CCOC(=O)c1ccc(F)c([N+](=O)[O-])c1
ethyl 4-fluoro-3-nitrobenzoate
CC1CCCCN1
2-methylpiperidine
CCOC(=O)c1ccc(N2CCCCC2C)c([N+](=O)[O-])c1
ethyl 4-(2-methylpiperidin-1-yl)-3-nitrobenzoate

Solvants

Conditions de réaction

Température
50°CELSIUS
Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    Autreto return to RT
  2. 2
    ExtractionIt was extracted with EtOAc
  3. 3
    Séchagethe organic phase was dried over sodium sulfate
  4. 4
    Concentrationconcentrated in vacuo

Mode opératoire

A mixture of ethyl 4-fluoro-3-nitrobenzoate (Clontech 01072, 1 g; 4.69 mmol; 1 eq.) and 2-methylpiperidine (1.395 g; 14.07 mmol; 3 eq.) in DMF (4 mL) was heated to 50° C. for 3 hours. The reaction was then allowed to return to RT and diluted with water. It was extracted with EtOAc and the organic phase was dried over sodium sulfate and concentrated in vacuo, affording ethyl 4-(2-methylpiperidin-1-yl)-3-nitrobenzoate as a yellow oil. The residue was taken up in THF (10 mL) and lithium hydroxide (561.73 mg; 23.46 mmol; 5 eq.) was added followed by water (10 mL). The reaction mixture was stirred at RT for 16 hours. It was concentrated and the residue was diluted with water and washed with Et2O. The aqueous layer was acidified to pH 5 with acetic acid. It was extracted with Et2O and the organic phase was dried over magnesium sulfate and concentrated, affording the title compound as a yellow solid (1.17 g, 94%). 1H NMR: (DMSO-d6, 300 MHz) δ 13.07 (s, 1H), 8.23-8.22 (d, J=2.13 Hz, 1H), 8.04-8 (dd, J=8.96 Hz, J=2.28 Hz, 1H), 7.44-7.41 (d, J=8.88 Hz, 1H), 3.64-3.60 (m, 1H), 3.25-3.17 (m, 1H), 2.90-2.84 (m, 1H), 1.82-1.43 (m, 6H), 1.06-1.04 (d, J=6.43 Hz, 3H). LC/MS (Method A): 265.0 (M+H)+; 263.0 (M−H)−.

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US08202865B2uspto-grants-2012_06